Osteoporosis and hyperthyroidism
Kopczyńska-Kowalczykowa; Sieradzki, J.; Ksiezyk, M.
Polski Przeglad Radiologii i Medycyny Nuklearnej 37(5): 589-595
1973
ISSN/ISBN: 0137-7183 PMID: 4756387 Document Number: 64694
Document emailed within 1 workday
Related Documents
Kitahama, S.; Ishii, T.; Wada, S. 2004: Osteoporosis in patients with hyperthyroidism Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 2): 711-717Saito, J.; Nishikawa, T. 2009: Osteoporosis treatment in patients with hyperthyroidism Nihon Rinsho. Japanese Journal of Clinical Medicine 67(5): 1011-1016
Wyler, B.; Bürgi, H.; Probst, P.; Schärer, K. 1986: Radioiodine therapy in hyperthyroidism: reliability of a long-term follow-up scheme for the diagnosis and treatment of hyperthyroidism based on the family physician and on a central registry Schweizerische Medizinische Wochenschrift 116(36): 1198-1204
Zagrobelny, Z. 1970: Effect of neuroleptoanalgesia, type Ii (NLA II) on the course of laboratory and clinical hyperthyroidism. I. Effect of NLA Ii on the thyroid function and its oxygen metabolism in experimental hyperthyroidism Endokrynologia Polska 21(5): 445-455
Pongchaiyakul, C.; Wanothayaroj, E. 2007: Performance of the Khon Kaen Osteoporosis Study (KKOS) score for identifying osteoporosis in men Journal of the Medical Association of Thailand 90(8): 1518-1523
Robin, J.C.; Ambrus, J.L. 1982: Studies on osteoporosis VI. Effect of human and salmon calcitonin on experimental osteoporosis Research Communications in Chemical Pathology and Pharmacology 35(3): 491-498
Zhang, X.; Lin, J.; Yang, X.; Fei, Q.; Wang, B.; Yang, Y.; Li, J.; Ma, Z.; Zhao, F.; Wang, Q. 2015: Investigation of osteoporosis prevalence and osteoporosis-related clinical risk factors among healthy elderly male Zhonghua Yi Xue Za Zhi 95(41): 3366-3369
Robin, J.C.; Sirianni, S.R.; Pragay, D.A.; Ambrus, J.L. 1981: Studies on osteoporosis. V. Comparison of methods of evaluation of osteoporosis and study of chromosome changes induced by neutron activation Journal of Medicine 12(4): 251-256
Suzuki, Y.; Wakabayashi, T. 2015: Management of osteoporosis associated with rheumatoid arthritis and glucocorticoid-induced osteoporosis Clinical Calcium 25(12): 1825-1834
Syc, S. 1971: Causes of cortisol-induced osteoporosis and Cushing's disease osteoporosis Wiadomosci Lekarskie 24(1): 41-43
Spencer, H.; Kramer, L. 1986: NIH Consensus Conference: osteoporosis. Factors contributing to osteoporosis Journal of Nutrition 116(2): 316-319
Joseph, P.; Hughes, D. 1997: Osteoporosis. Guidelines for general practitioners. Osteoporosis Australia Australian Family Physician 26(10): 1181-5 1188-91 1194-6
Chang, S.Fang.; Yang, R.Sen. 2014: Determining the cut-off point of osteoporosis based on the osteoporosis self-assessment tool, body mass index and weight in Taiwanese young adult women Journal of clinical nursing 23(17-18): 2628-2635
Scharla, S.H. 1999: Therapy of osteoporosis: native vitamin D or as hormone? Advantages of activated vitamin D in secondary osteoporosis MMW Fortschritte der Medizin 141(31-32): 32-36
Heidelmann, G. 1979: Problems of high-dose sodium fluoride therapy in osteoporosis. 3. Practice of osteoporosis therapy with sodium fluoride Zeitschrift für Arztliche Fortbildung 73(12): 581-584
Mezosi, E. 2006: Hyperthyroidism Orvosi Hetilap 147(28): 1309-1314
Mezosi, E. 2006: Hyperthyroidism Orvosi Hetilap 147(28): 1309-1314
Nilsen, L.B. 1976: Hyperthyroidism: the up and down of it Arizona Medicine 33(9): 727-729
Maji, D. 2006: Hyperthyroidism Journal of the Indian Medical Association 104(10): 563
Weiss, L. 1987: Hyperthyroidism Revue de l'Infirmiere 37(2): 25-27